SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-21-002768
Filing Date
2021-03-11
Accepted
2021-03-11 08:31:34
Documents
75
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-K blph-20201231x10k.htm   iXBRL 10-K 2548065
2 EX-4.5 blph-20201231xex4d5.htm EX-4.5 53185
3 EX-23.1 blph-20201231xex23d1.htm EX-23.1 3729
4 EX-31.1 blph-20201231xex31d1.htm EX-31.1 12116
5 EX-31.2 blph-20201231xex31d2.htm EX-31.2 12083
6 EX-32 blph-20201231xex32.htm EX-32 11572
7 GRAPHIC blph-20201231x10k003.jpg GRAPHIC 32615
  Complete submission text file 0001558370-21-002768.txt   9202021

Data Files

Seq Description Document Type Size
8 EX-101.SCH blph-20201231.xsd EX-101.SCH 50929
9 EX-101.CAL blph-20201231_cal.xml EX-101.CAL 53754
10 EX-101.DEF blph-20201231_def.xml EX-101.DEF 185170
11 EX-101.LAB blph-20201231_lab.xml EX-101.LAB 475730
12 EX-101.PRE blph-20201231_pre.xml EX-101.PRE 368164
13 EXTRACTED XBRL INSTANCE DOCUMENT blph-20201231x10k_htm.xml XML 1742370
Mailing Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059
Business Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059 908-574-4770
Bellerophon Therapeutics, Inc. (Filer) CIK: 0001600132 (see all company filings)

IRS No.: 473116175 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36845 | Film No.: 21731931
SIC: 2834 Pharmaceutical Preparations